Immutep Limited Stock Analysis & AI Score
Immutep Limited (IMMP) has an ST Score of 35.5 (C-), driven by its Forecast (A+) and held back by its Momentum (F). Analysts rate it Buy with a $4.25 price target (+1522.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Immutep Limited (IMMP) has an ST Score of 35.5 (C-), driven by its Forecast (A+) and held back by its Momentum (F). Analysts rate it Buy with a $4.25 price target (+1522.1% upside).
- Strongest
- ForecastA+
- Weakest
- MomentumF
All factor grades
- ForecastA+
- Financial StrengthB-
- GrowthC
- ValuationD
- ProfitabilityF
- MomentumF
- Piotroski4/9
Contact
IMMP stock: frequently asked questions
What is IMMP's ST Score?
Immutep Limited (IMMP) has an ST Score of 35.5 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IMMP a buy, hold, or sell?
Analysts rate IMMP a Buy, with a price target of $4.25 (+1522.1% vs the current price). Our ST Score grades it C- (35.5/100). The ST Score is a data-driven signal, not a recommendation.
What are IMMP's factor grades?
Valuation D, Profitability F, Financial Strength B-, Momentum F, Growth C, Forecast A+.
What is IMMP's valuation grade?
Immutep Limited (IMMP) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IMMP's growth grade?
Immutep Limited (IMMP) earns a growth grade of C, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IMMP's profitability grade?
Immutep Limited (IMMP) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IMMP's financial strength grade?
Immutep Limited (IMMP) earns a financial strength grade of B-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IMMP?
The average analyst price target for Immutep Limited (IMMP) is $4.25 from 4 analysts, which is +1522.1% versus the recent price of $0.26.
What is IMMP's Piotroski score?
Immutep Limited (IMMP) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.